GPT-Rosalind is a life science-specific scientific reasoning tool released by OpenAI on June 3, 2026, designed to support medicinal chemistry, genomics, quantitative biology, and laboratory problem-solving. Unlike typical conversational AI, which often only provides explanations for research questions, GPT-Rosalind focuses on connecting evidence retrieval, biological interpretation, Next-Generation Sequencing (NGS), and executable bioinformatics tasks into a single workflow. Similar to how GPT reads text and constructs contextually relevant answers, GPT-Rosalind acts as a research assistant that interprets life science questions and research data together, guiding users through the necessary analysis steps. It is described as supporting an interactive viewer that allows users to examine sequences, alignment results, and molecular structure files during the conversation. In traditional research workflows, literature searches, selection of analysis methods, execution of commands, visualization of results, and biological interpretation are often scattered across different tools and screens. Researchers typically find evidence in publications, then transfer the data to separate analysis software, import the output files into visualization tools, and manually review whether the results support the hypothesis. This process can easily lead to a loss of context between analysis steps, and the reproducibility and quality of the results can vary depending on the user's experience with the tools. The key differentiator of GPT-Rosalind is that it aims for an executable research workflow that connects retrieved evidence and data analysis results, and then interprets those results biologically, rather than simply providing biological question-and-answer responses. In particular, the ability to handle data that is difficult to understand from text alone, such as sequences, alignments, and molecular structures, in an interactive viewer can help bridge the gap between analysis results and explanations. From the perspective of a biotechnology researcher, it can be used for complex tasks such as candidate gene exploration, NGS result review, and medicinal chemistry hypothesis evaluation. For example, if a researcher asks about genes related to a specific phenotype, the system can search for relevant evidence, review available sequence or alignment files, and construct a workflow to interpret the observed variations or expression patterns. In NGS analysis, it is possible to organize the necessary steps, from quality control to alignment and variant or expression result review, through conversation, and then narrow down potential candidates for follow-up experiments by examining the generated results in an interactive viewer. In medicinal chemistry, it can serve as an aid to connect structural features and biological hypotheses by examining molecular structure files and literature evidence together. However, based solely on the provided Discovery information, it is not possible to confirm the actual supported file formats, the list of callable bioinformatics tools, analysis parameters, data retention policies, API availability, quantitative performance, and access conditions. Therefore, before entering sensitive patient genomic or clinical data, the official security and privacy documents, as well as the organization's data governance requirements, should be reviewed separately. The analysis results should also be validated through experimental design, statistical testing, and original literature, and should not be used alone for clinical judgment or regulatory decision-making.

GPT-Rosalind is a life science-specific scientific reasoning tool released by OpenAI on June 3, 2026, supporting medicinal chemistry, genomics, quantitative biology, and laboratory problem-solving. Unlike typical conversational AIs that tend to simply provide explanations for research questions, GPT-Rosalind focuses on connecting evidence retrieval, biological interpretation, Next-Generation Sequencing (NGS), and executable bioinformatics tasks into a single workflow. Just as GPT reads text and constructs contextually appropriate answers, GPT-Rosalind